Horizon Therapeutics Public Ltd Co

Brevan Howard Capital Management LP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

45,000

Value ($000)

5,206

Weight

1.5%

2023 Q1 - 2023 Q3 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	5,206	1.5%	45,000	9/30/2023
2023 Q2	8/14/2023	4,628	0.9%	45,000	6/30/2023
2023 Q1	5/15/2023	4,911	1.1%	45,000	3/31/2023